Daniela L Rus, a director at $SYM, sold 2,706 shares of the company on 07-10-2025 for an estimated $132,594. We received data on the trade from a recent SEC filing. This was a sale of approximately 10.2% of their shares of this class of stock. Following this trade, they now own 23,729 shares of this class of $SYM stock.
$SYM Insider Trading Activity
$SYM insiders have traded $SYM stock on the open market 36 times in the past 6 months. Of those trades, 0 have been purchases and 36 have been sales.
Here’s a breakdown of recent trading of $SYM stock by insiders over the last 6 months:
- TODD KRASNOW has made 0 purchases and 12 sales selling 76,000 shares for an estimated $2,141,967.
- WILLIAM M III BOYD (Chief Strategy Officer) has made 0 purchases and 9 sales selling 46,965 shares for an estimated $1,741,911.
- MICHAEL DAVID DUNN (Chief Customer Officer) has made 0 purchases and 6 sales selling 25,376 shares for an estimated $767,899.
- ROLLIN L. FORD sold 28,740 shares for an estimated $747,763
- CAROL J. HIBBARD (Chief Financial Officer) has made 0 purchases and 2 sales selling 8,683 shares for an estimated $229,153.
- DANIELA L RUS has made 0 purchases and 3 sales selling 4,706 shares for an estimated $192,594.
- MARIA G FREVE (See Remarks) sold 1,929 shares for an estimated $41,846
- MERLINE SAINTIL has made 0 purchases and 2 sales selling 1,209 shares for an estimated $40,281.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$SYM Hedge Fund Activity
We have seen 131 institutional investors add shares of $SYM stock to their portfolio, and 81 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- MORGAN STANLEY added 650,129 shares (+75.0%) to their portfolio in Q1 2025, for an estimated $13,139,107
- INVESCO LTD. removed 499,511 shares (-68.6%) from their portfolio in Q1 2025, for an estimated $10,095,117
- ZEVENBERGEN CAPITAL INVESTMENTS LLC removed 421,122 shares (-74.8%) from their portfolio in Q2 2025, for an estimated $16,360,589
- MILLENNIUM MANAGEMENT LLC added 414,399 shares (+1957.7%) to their portfolio in Q1 2025, for an estimated $8,375,003
- VANGUARD GROUP INC removed 396,896 shares (-8.0%) from their portfolio in Q1 2025, for an estimated $8,021,268
- BNP PARIBAS FINANCIAL MARKETS added 344,898 shares (+76.7%) to their portfolio in Q1 2025, for an estimated $6,970,388
- FMR LLC removed 297,007 shares (-30.7%) from their portfolio in Q1 2025, for an estimated $6,002,511
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$SYM Analyst Ratings
Wall Street analysts have issued reports on $SYM in the last several months. We have seen 6 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- Arete Research issued a "Buy" rating on 06/25/2025
- Citigroup issued a "Buy" rating on 04/14/2025
- BWS Financial issued a "Sell" rating on 04/02/2025
- Needham issued a "Buy" rating on 02/06/2025
- Cantor Fitzgerald issued a "Overweight" rating on 02/06/2025
- Northland Capital Markets issued a "Outperform" rating on 01/17/2025
- Oppenheimer issued a "Outperform" rating on 01/15/2025
To track analyst ratings and price targets for $SYM, check out Quiver Quantitative's $SYM forecast page.
$SYM Price Targets
Multiple analysts have issued price targets for $SYM recently. We have seen 9 analysts offer price targets for $SYM in the last 6 months, with a median target of $32.0.
Here are some recent targets:
- Michael Latimore from Northland Capital Markets set a target price of $56.0 on 07/08/2025
- An analyst from Arete Research set a target price of $50.0 on 06/25/2025
- Andrew Kaplowitz from Citigroup set a target price of $29.0 on 04/14/2025
- Mark Delaney from Goldman Sachs set a target price of $18.0 on 04/10/2025
- Hamed Khorsand from BWS Financial set a target price of $10.0 on 04/02/2025
- Chris Snyder from UBS set a target price of $30.0 on 02/25/2025
- Derek Soderberg from Cantor Fitzgerald set a target price of $60.0 on 02/06/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
